Business Description
![Cyclacel Pharmaceuticals Inc Cyclacel Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C00000JAM.png?14)
Cyclacel Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US23254L2079
Share Class Description:
CYCCP.PFD: 6% Convertible Exchangeable Preferred StockDescription
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 133.24 | |||||
Equity-to-Asset | -0.36 | |||||
Debt-to-Equity | -0.01 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -110.51 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 12 | |||||
3-Year EPS without NRI Growth Rate | 20 | |||||
3-Year FCF Growth Rate | 17 | |||||
3-Year Book Growth Rate | -80.7 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.52 | |||||
9-Day RSI | 50.2 | |||||
14-Day RSI | 43.04 | |||||
6-1 Month Momentum % | -42.68 | |||||
12-1 Month Momentum % | -37.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.58 | |||||
Quick Ratio | 0.58 | |||||
Cash Ratio | 0.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.84 | |||||
Forward Dividend Yield % | 7.79 | |||||
5-Year Yield-on-Cost % | 5.84 | |||||
3-Year Average Share Buyback Ratio | -36.5 | |||||
Shareholder Yield % | 2.12 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -5008.69 | |||||
Net Margin % | -4386.86 | |||||
ROE % | -365.16 | |||||
ROA % | -149.29 | |||||
ROIC % | -974.64 | |||||
ROC (Joel Greenblatt) % | -17820.13 | |||||
ROCE % | -413.01 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.54 | |||||
EV-to-Revenue | -0.16 | |||||
EV-to-FCF | 0.01 | |||||
FCF Yield % | -359.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CYCCP.PFD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cyclacel Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | 0 | ||
Beta | 1.15 | ||
Volatility % | 124.72 | ||
14-Day RSI | 43.04 | ||
14-Day ATR ($) | 0.769558 | ||
20-Day SMA ($) | 7.4 | ||
12-1 Month Momentum % | -37.06 | ||
52-Week Range ($) | 5.25 - 22.2 | ||
Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cyclacel Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cyclacel Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Cyclacel Pharmaceuticals Inc Frequently Asked Questions
What is Cyclacel Pharmaceuticals Inc(CYCCP.PFD)'s stock price today?
The current price of CYCCP.PFD is $7.70. The 52 week high of CYCCP.PFD is $22.20 and 52 week low is $5.25.
When is next earnings date of Cyclacel Pharmaceuticals Inc(CYCCP.PFD)?
The next earnings date of Cyclacel Pharmaceuticals Inc(CYCCP.PFD) is 2024-08-09 Est..
Does Cyclacel Pharmaceuticals Inc(CYCCP.PFD) pay dividends? If so, how much?
The Dividend Yield %  of Cyclacel Pharmaceuticals Inc(CYCCP.PFD) is 5.84% (As of Today), Highest Dividend Payout Ratio of Cyclacel Pharmaceuticals Inc(CYCCP.PFD) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Cyclacel Pharmaceuticals Inc(CYCCP.PFD) is 7.79%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |